Visit Contract Pharma
at Booth 1815

Recro Gainesville Hires Industry Veteran


Heather Sugrue to lead the CDMO's business development team

Recro Gainesville, LLC, a wholly owned subsidiary of Recro Pharma, Inc., and a provider of solid oral dose manufacturing services for the pharmaceutical industry, has named Heather Sugrue as head of business development, North America.

Recro is a contract development and manufacturing organization (CDMO) that specializes in extended release and controlled substances, offering capabilities in formulation development, analytical method development, manufacturing, and packaging and logistics.

Ms. Sugrue leads Recro's North American business development executive team, driving new business and strengthening existing client relationships within the global pharmaceutical mar-ket. Conducting competitive intelligence to understand clients' strategic objectives, she also functions as a liaison between clients and Recro's internal teams, establishing a culture of co-operation and best practice sharing that drives success and aligns with the company's custom-er-focused approach.

Prior to joining Recro, Ms. Sugrue spent five years as senior director of business development at Patheon, where she led the West Coast business development team across multiple busi-ness units, achieving consistent year-over-year growth. She also served as senior director of business development at Ricerca Biosciences and MDS Pharma Services. Ms. Sugrue has more than a decade of experience as an account manager at PerkinElmer, Invitrogen and Bio-Rad Laboratories and has received numerous awards.

"Heather is an industry veteran whose breadth and depth of experience is unparalleled, and she is integral to Recro's long-term strategic initiatives as an expanding CDMO," said Scott Riz-zo, general manager, Recro Gainesville. "She brings key leadership and coaching skills, thrives at building growth and has a talent for identifying client needs and establishing win-win rela-tionships with organizations of any size."